Cardiovascular Engineering and Technology Impact Factor 2026: 2.53

Publishing your own paper?

Get it ready for the right journal with a PhD expert in your field.

Manuscript Auditing

A PhD reviewer in your exact area sends a structured, section-by-section critical review.

AI plagiarism and similarity report included
Secure, confidential upload

Audit duration: within 1 weekCheck price →

If the journal needs LaTeX

LaTeX Template Conversion

We convert your manuscript into the LaTeX template your target journal requires.

Check price →

If your paper was out of scope

Journal Selection & Submission

Up to 5 journals matched to your indexing (SCIE / Scopus) and quartile
Submission handled, with weekly updates

With LaTeX conversion: within 2 Working DaysCheck price →

What is ScholarsColab?

ScholarsColab is a freelancing platform built for researchers, with a pool of research doctorates registered to mentor them. Hire one in your research area and cut your research timeline from 2 years to 2 months.

Know more →

At a glanceCardiovascular Engineering and Technology is listed in SCIE, Scopus, JCR 2024. Published by Springer Science+Business Media, it has 864 published works, cited 12,064 times (h-index 48). Its impact factor* of 2.53 ranks it 74 of 250 in Cardiac & Cardiovascular System. Its papers take a median of 191 days from submission to acceptance. 68% of its recent research articles name a funder, most often National Natural Science Foundation of China. Papers by ScholarsColab mentors and the researchers we track appear here as soon as they publish in it. Data updated 22 October 2026.

Official website Guide for authors and submission Check my manuscript first

Impact factor*2.53Rank 74 of 250 in Cardiac & Cardiovascular System IndexingSCIEScopusJCR 2024Confirm on the official lists before you submit Review time191 daysMedian from submission to acceptance

RetractionsNoneNone on record under this name

LaTeX template available

Springer Publishing Company provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.

LaTeX Template Conversion →

01Impact factor

Impact factor of Cardiovascular Engineering and Technology (2026)

Impact factor (2-year)2.53calculated by ScholarsColab

Rank in category#74of 250 by citedness

APC (listed)US$3,790article charge

h-index48

Papers published864cited 12,064 times

The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Cardiovascular Engineering and Technology published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.

Rank in its subject categories

Cardiac & Cardiovascular Systemrank 74 of 250 journals
Engineering, Biomedicalrank 83 of 126 journals

Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.

Quartile of Cardiovascular Engineering and Technology

A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Cardiovascular Engineering and Technology is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.

Citations and papers per year

Citations per year

Papers per year

Article processing charge listed at about US$3,790.

Please check the final impact factor. The impact factor and APC on this page are calculated by ScholarsColab (updated 17 October 2026) and can differ from the official values. Confirm the current impact factor and charges on the journal’s website or in Clarivate’s Journal Citation Reports before you submit.

Is your paper a fit for Cardiovascular Engineering and Technology?

Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.

Check my paper for this journal Or find journals that fit my paper

02Review time

Review time of Cardiovascular Engineering and Technology

Submission to acceptance191 daysmedian

Acceptance to online17 daysmedian

Papers counted109Oct 2024 to Oct 2026

How long papers in this journal took to be accepted

Fastest 10% accepted within 106 daysMiddle half of the papers: 152–278 daysMedian: 191 daysSlowest 10% took over 350 days

Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.

Full analysis: your chances within 3 or 6 months, dates and faster journals →

Half of the research articles Cardiovascular Engineering and Technology published between Oct 2024 and Oct 2026 were accepted within 191 days of submission, and the middle half took between 152 and 278 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.

In Cardiac & Cardiovascular System, Cardiovascular Engineering and Technology ranks 74 of 83 journals by review time (1 = fastest). See the fastest-review journals in Cardiac & Cardiovascular System →

Want a journal with a shorter review time for your manuscript? Journal Selection & Submission shortlists matching journals and handles the submission.

Source, method and date. For each of the 109 research articles published from Oct 2024 to Oct 2026 that carry both dates, ScholarsColab counted the days from received to accepted, then took the median and the middle 50% of those values; articles with impossible dates were left out. Updated: 29 October 2026, refreshed about every 3 months. Review times of individual papers vary with the field, the editor, the reviewers and the number of revisions, and the journal may count from a different date. ScholarsColab is not affiliated with this journal; check the journal’s website for its own figures.

Need a faster review? Cardiovascular Engineering and Technology takes a median of 191 days; the fastest journals in Cardiac & Cardiovascular System take 39.

Echocardiography 39 days
CardioVascular and Interventional Radiology 43 days
Current Treatment Options in Cardiovascular Medicine 44 days

All fastest journals in this field

APC waivers and discounts for Cardiovascular Engineering and Technology APC about US$3,790

Springer Nature: 100% waiver for low-income countries and 50% for lower-middle income countries (World Bank list with a GDP limit), on request at submission. Authors in 25 countries get a full waiver.

Check the APC for my country

03Funders

Who funds research published in Cardiovascular Engineering and Technology

Articles naming a funder68%of 109 recent articles

Funders named most often

National Natural Science Foundation of China6

National Heart, Lung, and Blood Institute5

National Science Foundation4

American Heart Association3

National Institutes of Health3

A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.

Based on up to 200 research articles this journal published in the last 24 months. Not every article lists its funders, so the share can be lower than the real one. Updated: 29 October 2026.

04Indexing

Indexing of Cardiovascular Engineering and Technology

List	Status
Science Citation Index Expanded (SCIE)	✓ Listed
Social Sciences Citation Index (SSCI)	Not listed
Arts & Humanities Citation Index (AHCI)	Not listed
Emerging Sources Citation Index (ESCI)	Not listed
Scopus	✓ Listed
Journal Citation Reports 2024	✓ Listed

ISSN: 1869-408X
eISSN: 1869-4098
Publisher: Springer Publishing Company all its journals →
Country: United States
Language: English
Scopus source type: Journal
Web of Science categories: Cardiac & Cardiovascular System, Engineering, Biomedical

From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).

Verify the indexing yourself

Each link opens the official record for this journal, searched by its ISSN where we have one.

05How to submit

How to submit to Cardiovascular Engineering and Technology

Read the guide for authors. It sets the article types, word limit, reference style and file format that Cardiovascular Engineering and Technology accepts. Open the official guide for authors and submit from the same page.
Use the journal's template. Springer Publishing Company offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
Check the fee. Cardiovascular Engineering and Technology is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.

06Reviewer comments

Reviewer comments and rejection reasons for Cardiovascular Engineering and Technology

No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.

Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Cardiovascular Engineering and Technology, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.

Audit my paper before I submit →

Worried about the English? Manuscript editing by editors in your subject: see the price →

Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds

07Same subject

Cardiac & Cardiovascular System journals with a similar impact factor*

The journals next to Cardiovascular Engineering and Technology when the 234 journals of Cardiac & Cardiovascular System in our data are ranked by impact factor*:

Rank	Journal	Impact factor*	Indexing	Open access
70	International Journal of Cardiology	2.59	SCIE	Subscription
71	Hellenic Journal of Cardiology	2.59	SCIE	Fully open access
72	Journal of Cardiology	2.55	SCIE	Subscription
73	Cardiovascular Diagnosis and Therapy	2.54	SCIE	Fully open access
75	Journal of Cardiovascular Translational Research	2.49	SCIE	Subscription
76	American Journal of Preventive Cardiology	2.49	ESCI	Fully open access
77	Interventional Cardiology Reviews Research Resources	2.48	ESCI	Fully open access
78	Frontiers in Cardiovascular Medicine	2.46	SCIE	Fully open access

*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.

FreeNo AI

Is Cardiovascular Engineering and Technology right for your paper? Find the right journal

Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.

Try:

Publishing open access? Your author team may not have to pay the APC. Free APC waiver check for your country→

How it works

No AI or language model is used. Your words are matched against the titles of 157,109 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.

Want a PhD expert to shortlist and handle the submission? Journal Selection & Submission matches your manuscript to up to 5 suitable journals by indexing and quartile. Check price →

08Questions

Frequently asked questions

How long is the review time of Cardiovascular Engineering and Technology?

Based on 109 research articles Cardiovascular Engineering and Technology published from Oct 2024 to Oct 2026, the median time from submission to acceptance was 191 days, and half of them were accepted between 152 and 278 days. After acceptance, papers appeared online after a median of 17 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.

What is the impact factor of Cardiovascular Engineering and Technology?

Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Cardiovascular Engineering and Technology is 2.53: papers it published in the two previous years were cited 2.53 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.

What is the h-index of Cardiovascular Engineering and Technology?

The h-index of Cardiovascular Engineering and Technology is 48 (October 2026): 48 of its papers have each been cited at least 48 times. Its i10-index is 349.

What is the APC of Cardiovascular Engineering and Technology?

The listed article processing charge (APC) is about US$3,790 for Cardiovascular Engineering and Technology (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.

What is the quartile of Cardiovascular Engineering and Technology?

Is Cardiovascular Engineering and Technology indexed in Scopus?

Yes. Cardiovascular Engineering and Technology appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Cardiovascular Engineering and Technology an SCIE journal?

Yes. Cardiovascular Engineering and Technology is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.

Is Cardiovascular Engineering and Technology in Journal Citation Reports (JCR)?

Yes. Cardiovascular Engineering and Technology is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.

Does Cardiovascular Engineering and Technology offer an APC waiver?

Cardiovascular Engineering and Technology follows the policy of Springer Nature: 100% waiver for low-income countries and 50% for lower-middle income countries (World Bank list with a GDP limit), on request at submission. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.

Who funds research published in Cardiovascular Engineering and Technology?

68% of 109 recent research articles in Cardiovascular Engineering and Technology name a funder; the funders named most often are National Natural Science Foundation of China, National Heart, Lung, and Blood Institute, National Science Foundation.